Hospira, Stada Collaboration To Yield Biosimilar EPO In The EU Ahead Of U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
Hospira obtains exclusive distribution rights for Bioceuticals erythropoietin in the EU and will be solely responsible for U.S. development.